Staar Surgical (STAA) Cost of Revenue (2010 - 2026)

Staar Surgical (STAA) has 17 years of Cost of Revenue data on file, last reported at $24.5 million in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue rose 68.05% year-over-year to $24.5 million; the trailing twelve-month figure through Apr 2026 stood at $66.9 million (down 50.2% YoY), and the FY2026 full-year result was $57.0 million, down 51.25% from the prior year.
• Cost of Revenue for Q2 2026 stood at $24.5 million, up from $14.1 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $60.0 million in Q4 2024 and bottomed at $11.5 million in Q2 2025.
• The 5-year median for Cost of Revenue is $24.2 million (2022), against an average of $24.0 million.
• The widest annual swing landed in 2024, when Cost of Revenue soared 126.11%; it then tumbled 76.55% in 2026.
• A 5-year view of Cost of Revenue shows it stood at $24.2 million in 2022, then rose by 9.48% to $26.5 million in 2023, then jumped by 126.11% to $60.0 million in 2024, then slumped by 71.89% to $16.9 million in 2025, then soared by 45.39% to $24.5 million in 2026.
• The last three Cost of Revenue figures came in at $24.5 million (Q2 2026), $14.1 million (Q1 2026), and $16.9 million (Q3 2025), per Business Quant data.

Peer Comparison